The Paradigm Evolves

November 13 – 14, 2019 • Harvard Medical School, Boston, MA

The 15th Annual Personalized Medicine Conference at Harvard Medical School will explore the science, business, and policy issues facing personalized medicine as scientists refine their understanding of how groundbreaking molecular diagnostics augmented by artificial intelligence, advanced data analytics, and digital health applications can empower both physicians and patients with information about how an expanded set of biological characteristics — including those found in the proteome and microbiome — may influence their health and their responses to increasingly impactful therapies.

  • With gene therapies, cell-based regenerative medicine, more targeted therapies, and the introduction of better tools for delivering therapies from digital health apps to artificial intelligence to next-generation sequencing, we’re living in an age of momentous progress and rapid cycles of innovation.

    Scott Gottlieb, M.D., Resident Fellow, American Enterprise Institute
  • With new biomarkers coming on line, we probably will be able to diagnose much better who will respond best to therapy. That means we have to develop drugs and diagnostics together.

    Paul Stoffels, M.D., Vice Chairman, Executive Committee, Chief Scientific Officer, Johnson & Johnson
  • It is important that the research, medical, and pharmaceutical communities collaborate to maintain momentum in personalized medicine so that we are able to deliver cutting-edge care and clinical trial opportunities to all patients.

    Carl June, M.D., Richard W. Vague Professor in Immunotherapy, University of Pennsylvania

Conference

Learn about the venue, organizers and history of the conference.

LEARN MORE

Schedule

View the conference program.

Schedule

Speakers

View a list of confirmed speakers.

Speakers

Featured Speakers

Bonnie J. Addario

Co-Founder, Chair

GO2 Foundation for Lung Cancer

Scott Gottlieb, M.D.

Resident Fellow

American Enterprise Institute

Carl June, M.D.

Richard W. Vague Professor in Immunotherapy

University of Pennsylvania

Nancy Mendelsohn, M.D.

Chief Medical Officer, Special Needs Initiative

UnitedHealth Group

Joshua Ofman, M.D.

Chief of Corporate Strategy and External Affairs

Grail

Steven Shak, M.D.

Chief Scientific Officer

Genomic Health

Kenna R. Mills Shaw, Ph.D.

Executive Director

MD Anderson Institute for Personalized Cancer Therapy

Paul Stoffels, M.D.

Vice Chairman, Executive Committee; Chief Scientific Officer

Johnson & Johnson

Meg Tirrell

Reporter

CNBC

View full List of Speakers

Sponsors

View full List of Sponsors